Table 5.
Origin of CSC | Hallmarks of CSC | Drug resistance | Ref. |
Tumorigenic cells in colon cancer were isolated by mechanical and enzymatic dissociation. CD133 cells were separated magnetically or using a cell sorter | Tumorigenic cells in colon cancer were in the high-density CD133+ cells. CD133+ cells readily reproduced the original tumor in nude mice, but CD133- cells did not form tumors | No description | Ricci-Vitiani et al.[54] |
Colon cancer specimens were sliced and enzymatically dissociated. CSC cultures were made in a human embryonic stem cell medium with modification | Cell sorting was done on a MoFlo High Speed Cell Sorter using CD133 and EpCAM antibodies. Colon CSCs could be isolated and proliferate under serum-free and stem cell culture conditions. These spheroid forming cells express well-known CSC markers, such as CD133, CD166, CD44, and EpCAM | Relatively larger (> 70%) cell growth of spheroidal cells (showing CSC characteristics) was observed in irinotecan concentrations of 2 and 4 mM. Growth of differentiated cells (not showing CSC characteristics) at 2 and 4 mM was only 35%-40%. At 51 mM irinotecan, growth of spheroid cells and differentiated cells were approximately 35% and 10%, respectively | Fang et al.[55] |
Human colon cancer cell line, COLO 205, cells were maintained in a medium free of serum | Culture under a serum-free condition for 7 days, and then CD133 expression was confirmed (CSC-like). The CSC-like cells express CYP3A4 and ALDH1A1 as compared with standard medium containing serum | CSC-like cells showed higher viability when exposed to oxaliplatin, cisplatin, gemcitabine, vinblastine, and etoposide | Olszewski et al.[56] |
Patient-derived colorectal cancer cells (CRC1) maintained as spheroids | CRC1 cells maintained as spheroids showed a higher expression of ALDH activity, a CSC marker, than cells in 2D culture | Spheroidal cells were 2.44-fold more resistant to combinatory treatment of 5-fluorouracil and SN-38 than 2D cells | Planque et al.[58] |
CSC: Cancer stem cell.